Global Iohexol API market cagr 12.9%

Page 1


Iohexol API Market

Iohexol API Market Scope: Industry Analysis, Market

Size, Growth, Trends Till 2031

Request Sample Report

Iohexol API Market Size and Growth

The Iohexol API market is experiencing steady growth due to increasing diagnostic imaging demands and expanding healthcare infrastructure. As of 2023, the market size is estimated at approximately USD 150 million, driven by rising prevalence of chronic diseases and technological advancements in contrast media, enhancing imaging efficacy and patient outcomes.

Companies Covered

(Covid 19 Impact Covered)

◍ GE Healthcare

◍ BeiLu Pharma

◍ Fuji Pharma

◍ Stellite

◍ Haichang Pharmaceutical

The Iohexol API market features key players like GE Healthcare, BeiLu Pharma, Fuji Pharma, Stellite, and Haichang Pharmaceutical. These companies manufacture Iohexol for diagnostic imaging, enhancing market growth through innovative formulations and expanded applications. Notable sales figures include GE Healthcare's $19 billion and BeiLu Pharma's approximate $800 million in annual revenue.

Request Sample Report

Market Segmentation

By Application

Request Sample Report

By Product

Market Growth

Request Sample Report

$ X Billion USD

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.